Table 1.
Protocols tested, platelet counts in venous blood, platelet-poor plasma, platelet-rich plasma and enrichment percentage in the pilot study*
33[334_alcaep]2.0.co;2/5/i1548-1336-33-6-334-t01.gif?Expires=1689154098&Signature=gbrcrn5iJg4Zs7oeM2kvSA99avNSn87sWrhwowxOwL2b3Lu~jFBNP4mRlONwjzRtlXaQot0rWOr0gKvA-Ir~rH1P0KVA5sUwk0h7gPfgciS0SNX45-ehapbSgGPggT61xkHPAjCj99NhbBr63nxVfUpd~tICJ4RgSWPZm8ro4Gf~oacTZsOM~UAbPYvrW-A9mRylCy9t5JmjqRtNb0ppUFudA-pv9G9iA6GJaJoD7qZC-4dJpo85XTrHoB4EJTZsS8vK09cI484yZcFqvghuneiw-qp41LhZr8dwVbARtqjg1N4XMW4hNq3JdQ4~1y42NI3pbZZJggoTkYcMtvweeA__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Protocols tested, platelet counts in venous blood, platelet-poor plasma, platelet-rich plasma and enrichment percentage in the pilot study*